Analyst Dylan Van Haaften of Stifel Nicolaus maintained a Hold rating on Smith & Nephew (SN – Research Report), with a price target of p1,025.00.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Dylan Van Haaften has given his Hold rating due to a combination of factors related to Smith & Nephew’s recent performance and future outlook. The company’s first-quarter results were generally in line with expectations, with some positive signs in the Orthopaedics segment, particularly in Knee Implants. However, the overall guidance for the year remains ambitious, requiring significant acceleration in the latter half of the year, which introduces a level of uncertainty.
Despite the Orthopaedics unit showing some promise, other segments like Advanced Wound Management slightly missed expectations. Additionally, the impact of tariffs and macroeconomic factors could pose challenges. Given these mixed signals, Van Haaften’s Hold rating reflects a cautious stance, acknowledging both the potential for growth and the risks associated with achieving the company’s ambitious targets.
According to TipRanks, Van Haaften is ranked #8289 out of 9371 analysts.
In another report released on April 25, HSBC also downgraded the stock to a Hold with a £10.70 price target.